Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 1
1984 1
1985 1
1989 1
1990 2
1991 1
1992 4
1993 4
1994 5
1995 3
1996 2
1997 5
1998 1
1999 1
2000 4
2001 2
2002 7
2004 1
2005 6
2006 2
2009 1
2010 3
2011 2
2012 2
2013 2
2014 5
2015 3
2016 4
2017 7
2018 6
2019 9
2020 12
2021 5
2022 5
2023 5
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Mirza MR, Chase DM, Slomovitz BM, dePont Christensen R, Novák Z, Black D, Gilbert L, Sharma S, Valabrega G, Landrum LM, Hanker LC, Stuckey A, Boere I, Gold MA, Auranen A, Pothuri B, Cibula D, McCourt C, Raspagliesi F, Shahin MS, Gill SE, Monk BJ, Buscema J, Herzog TJ, Copeland LJ, Tian M, He Z, Stevens S, Zografos E, Coleman RL, Powell MA; RUBY Investigators. Mirza MR, et al. N Engl J Med. 2023 Jun 8;388(23):2145-2158. doi: 10.1056/NEJMoa2216334. Epub 2023 Mar 27. N Engl J Med. 2023. PMID: 36972026 Clinical Trial.
Effectiveness of Tildrakizumab 200 mg in Moderate-to-Severe Plaque Psoriasis: A Multicenter Real-World Study Analyzing Patient Outcomes by Weight, PASI, BMI, and Previous Therapies.
Trovato E, Bianchelli T, Odorici G, Cuccia A, Di Lernia VG, Lasagni C, Manfredini M, Nicolini M, Rech G, Satolli F, Cartocci A, Bardazzi F, Campanati A. Trovato E, et al. Among authors: nicolini m. Dermatol Ther (Heidelb). 2025 Jul;15(7):1941-1952. doi: 10.1007/s13555-025-01442-x. Epub 2025 May 24. Dermatol Ther (Heidelb). 2025. PMID: 40413278 Free PMC article.
Psychopathology in premanifest C9orf72 repeat expansion carriers.
De Vocht J, Stam D, Nicolini M, Lamaire N, Laroy M, Vande Casteele T, Van De Vliet L, Vansteelandt K, D'Hondt A, Emsell L, Bruffaerts R, Vandenbulcke M, van Damme P, Van den Stock J. De Vocht J, et al. Among authors: nicolini m. J Neurol Neurosurg Psychiatry. 2022 May;93(5):565-567. doi: 10.1136/jnnp-2021-327774. Epub 2021 Sep 28. J Neurol Neurosurg Psychiatry. 2022. PMID: 34583943 No abstract available.
A prospective Real-Life Multicenter Study of Tildrakizumab 200 mg in Patients with Moderate-Severe Psoriasis: Who is the Ideal Patient?
Di Brizzi EV, Caccavale S, Di Caprio R, Cusano F, De Pasquale R, Falcomatà V, Foti C, Giofrè C, Gubinelli E, Mazzocchetti G, Nicolini M, Palazzo G, Pescitelli L, Puca RV, Sarno O, Balato A. Di Brizzi EV, et al. Among authors: nicolini m. Dermatol Pract Concept. 2024 Oct 30;14(4):e2024284. doi: 10.5826/dpc.1404a284. Dermatol Pract Concept. 2024. PMID: 39453881 Free PMC article.
Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?
Cazzaniga ME, Cortesi L, Ferzi A, Scaltriti L, Cicchiello F, Ciccarese M, Torre SD, Villa F, Giordano M, Verusio C, Nicolini M, Gambaro AR, Zanlorenzi L, Biraghi E, Casini E, Legramandi L, Rulli E. Cazzaniga ME, et al. Among authors: nicolini m. Int J Breast Cancer. 2017;2017:1683060. doi: 10.1155/2017/1683060. Epub 2017 Dec 3. Int J Breast Cancer. 2017. PMID: 29333297 Free PMC article. Review.
Neuroprotective effects of low-doses of aspirin.
Persegani C, Russo P, Lugaresi E, Nicolini M, Torlini M. Persegani C, et al. Among authors: nicolini m. Hum Psychopharmacol. 2001 Mar;16(2):193-194. doi: 10.1002/hup.257. Hum Psychopharmacol. 2001. PMID: 12404590
113 results